Virtus Investment Partners, Inc. (VRTS) is a Hartford, Connecticut-based multi-boutique asset manager, not an exchange-traded fund (ETF). Its stock has a modest but unusually divided sell-side following. Four current, attributable analyst targets were reviewed: Piper Sandler at $146 (Oct 19, 2026, Overweight), TD Cowen at $136 (Oct 29, 2026, Hold), Morgan Stanley at $120 (Oct 28, 2026, Underweight), and Barclays at $117 (Oct 14, 2026, Underweight).
The overall average of these four targets is about $129.75, only roughly 4% above the recent price — not enough to form a meaningful target on its own. Applying a minimum-distance discipline, the central target of $141 is instead the average of the two targets above the current price ($136 and $146). The full range is wide, from $117 to $146, reflecting genuine disagreement about whether outflows will stabilize.
Recent revisions have been predominantly downward. Piper Sandler's Crispin Love cut from $172 to $146; Barclays' Benjamin Budish cut from $135 to $117; TD Cowen's Bill Katz cut from $155 to $136; and Morgan Stanley's Michael Cyprys cut from $130 to $120. The overall recommendation mix is one Buy, one Hold, and two Sells, underscoring a cautious analyst consensus.
With shares near $124.97, a move to $141 represents an upside of roughly 13% — a substantial but not extreme move for an asset manager. The stock trades near the lower end of its 52-week range of about $117.44 to $175.66, well below last year's highs.
The path would likely require a stabilization, then improvement, in net flows and fee revenue. Valuation is undemanding at a trailing price-to-earnings (P/E) ratio near 7, and the stock offers a forward dividend of $9.80 per share, or roughly a 7.8% yield, which can support the share price even when growth is weak. However, any sustained re-rating toward $141 would probably depend on evidence that AUM erosion is bottoming and that earnings estimates stop falling.
The most credible supports are valuation and income. A single-digit P/E and an outsized dividend yield mean the market is already pricing in considerable pessimism, leaving room for upside if conditions stabilize. The company reported preliminary AUM of about $141.4 billion as of September 30, 2026, and noted positive net flows in exchange-traded funds and tender offer funds — areas where fee growth can be stickier. Strong financial markets, which lift AUM and fee revenue, would be the clearest catalyst for an upward re-rating.
The primary obstacle is the outflow picture. Third-quarter AUM declined from the prior quarter, with net outflows across retail separate accounts, institutional accounts, U.S. retail funds, and global funds. The company also disclosed that a roughly $7 billion institutional subadvisory mandate will terminate in October, which, while lower-fee, adds to the narrative of shrinking assets. Two of four analysts carry Sell-equivalent ratings, and consensus EPS (earnings per share) estimates are trending lower. Persistent outflows, weak markets, or further negative estimate revisions could keep shares anchored near the lower end of the range.
The 52-week high near $175.66 and low near $117.44 frame the long-term structure. The stock is trading much closer to its low than its high. The $117 area acts as a key support level, while $130 to $136 represents the first meaningful resistance level zone, followed by the $146 analyst target. A sustained break above $146 would be required to signal a shift in the prevailing downtrend; conversely, a loss of $117 could open the door to further downside.
Analyst price targets generally reflect a roughly 12-month research horizon, though individual methodologies vary. The most important near-term event is the company's third-quarter earnings report, rescheduled to November 9, 2026, which should clarify fee revenue, margins, and any flow commentary. Investors should also monitor monthly AUM updates, the impact of the $7 billion mandate loss, analyst estimate revisions, dividend sustainability, and broader equity and credit market conditions that drive asset values.
For traders seeking a more systematic view, Tickeron's AI Daily Buy/Sell Signals use artificial intelligence to continuously monitor thousands of stocks and ETFs, generating Buy, Sell, or Hold signals based on changing market conditions, technical behavior, and AI-driven analysis. The tool is designed to help users discover opportunities, keep track of positions, and identify shifting trends more efficiently than manual screening alone. Traders can use these signals alongside fundamental research to stay alert to momentum changes as they unfold.
Can VRTS reach $141? The central target, derived from the average of the two above-price analyst targets, would require roughly a 13% advance from recent levels. The case rests on a low valuation, a high dividend yield, and any stabilization in flows, while the risks center on persistent outflows, a $7 billion mandate termination, and a predominantly bearish analyst stance. The wide $117-to-$146 range and the overall $129.75 mean illustrate that even the bulls see only modest upside. Whether the stock reaches $141 will depend largely on the November earnings report and evidence that AUM declines are abating. No outcome is guaranteed, and investors should weigh both the valuation support and the flow headwinds before drawing conclusions.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
A.I.dvisor indicates that over the last year, VRTS has been loosely correlated with FHI. These tickers have moved in lockstep 57% of the time. This A.I.-generated data suggests there is some statistical probability that if VRTS jumps, then FHI could also see price increases.
| Ticker / NAME | Correlation To VRTS | 1D Price Change % | ||
|---|---|---|---|---|
| VRTS | 100% | +1.99% | ||
| FHI - VRTS | 57% Loosely correlated | +0.52% | ||
| BLK - VRTS | 56% Loosely correlated | +0.70% | ||
| VCTR - VRTS | 53% Loosely correlated | +6.08% | ||
| BAM - VRTS | 52% Loosely correlated | +0.93% | ||
| BEN - VRTS | 52% Loosely correlated | +4.72% | ||
More | ||||